Cardiovascular pharmacotherapy. Hemodynamic drugs and antiarrhythmic agents.
Successful management of the patient presenting with acute cardiovascular compromise requires a thorough working knowledge of the therapeutic agents available for treatment. This article focuses on the indications for, dosing, and monitoring employed for successful use of the vasoactive agents and antiarrhythmic medications in current widespread use in the veterinary intensive care setting.
Laste
N J
NJ
Section of Cardiology, Department of Internal Medicine, Angell Memorial Animal Hospital, Boston, Massachusetts, USA. nlaste@angell.org
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000662:veterinary*; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004638:Emergency Treatment / Q000662:veterinary
D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents